Insert Cover Image using Slide Master View                                Do not distortAnti-Infective Pharmaceuticals Mar...
Executive Summary                   Anti-infective pharmaceuticals market in India is valued at INR X bn in 20--    Market...
•Introduction•Market Overview•Drivers & Challenges•Government Initiatives•Drug Regulation and Patents•Competition•Strategi...
Indian anti-infectives market is expected to witness an enormous growth over the coming years Indian Market – Overview    ...
Drivers & Challenges – Summary  Drivers                                                             Challenges  Increasing...
Government Initiatives – Summary           Changes in tax structure                       Control programmes              ...
Major domestic players in the market (1/9) Company Snapshot: Company 1Corporate Information                               ...
Thank you for the attentionThe Anti-Infective Pharmaceuticals Market – India report is part of Netscribes’ HealthcareIndus...
Upcoming SlideShare
Loading in …5
×

Market Research Report : Anti Infective Pharmaceuticals Market in India 2011

1,491 views

Published on

For the complete report, get in touch with us at : info@netscribes.com

Anti-infective pharmaceuticals market in India is the largest contributor to domestic pharmaceutical sales, contributing around 18%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for anti-infective drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the patient population, increasing number of vaccine approvals, increase in health insurances and introduction of newer and better drugs is helping the market to grow. The Indian Government, on its part, has introduced some control programmes, undertaken various Private Partnership Projects (PPP) and has taken initiatives to reduce drug prices. The market is expected to exhibit steady growth over the next few years.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,491
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
35
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Market Research Report : Anti Infective Pharmaceuticals Market in India 2011

  1. 1. Insert Cover Image using Slide Master View Do not distortAnti-Infective Pharmaceuticals Market - IndiaSeptember 2011
  2. 2. Executive Summary Anti-infective pharmaceuticals market in India is valued at INR X bn in 20-- Market Market is expected to grow at a CAGR of x% from 20–--- Anti infectives are the largest contributor to domestic sales, contributing around y% Drivers: Challenges: Increasing patient population Pricing pressure Drivers and Increasing number of vaccine approvals Logistic problems in the vaccine market Challenges Increase in health insurances Introduction of new drugs Phases of clinical trialDrug regulation Approval and licensing of drugs and patents Patents Highly fragmented market with large number of players Major foreign players in the market include Gilead inc, Abbott, Glaxosmithkline etc Competition Major domestic companies include Ranbaxy, Cipla, Dr. Reddy’s, Sun Pharmaceuticals, Panacea Biotech, Torrent Pharmaceuticals among others Strategic Foray into the adult vaccine marketrecommendations Partnership with Governmental and private bodies ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT 2
  3. 3. •Introduction•Market Overview•Drivers & Challenges•Government Initiatives•Drug Regulation and Patents•Competition•Strategic Recommendations ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT 3
  4. 4. Indian anti-infectives market is expected to witness an enormous growth over the coming years Indian Market – Overview Market Size and Growth • Anti-infectives belong to the acute segment which INR bn makes up around z% of the total pharmaceutical 200 industry x% x6 150 x5 Anti-infectives are the largest contributor to domestic x4 x3 pharmaceuticals sales, contributing around y% x2 100 x1 Cephalosporins, penicillins and quinolones are key drug classes among anti-infectives, with a share of around z% of 50 the country’s anti-infectives market 0 • Presently the market has a size of INR X bn, and is 2010 2011e 2012e 2013e 2014e 2015e expected to grow at a CAGR of x% from 20----- • In 2010 GSK’s Augmentin was the highest selling drug Top pharmaceutical segments – 2010 with sales of INR Y bn 0 2 4 6 8 10 12 14 16 18 Zifi, Taxim ,Monocef, Mox, Taxim-O , Zinacef and Gerimac % anti-infectives y1 were the other top selling drugs CVS y2 • India has emerged as one of the leading vaccine gastro y3 manufacturer in recent times, producing z% of the CNS y4 global health vaccines respiratory y5 Pentaxim, Varivax and Prevenar were the top selling diabetes y6 vaccines in 20-- pain y7 oncology y8Source: ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT 4
  5. 5. Drivers & Challenges – Summary Drivers Challenges Increasing patient population Pricing pressure Increasing number of vaccine Logistic problems in the vaccine approvals market Increase in health insurances Introduction of new drugs ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT 5
  6. 6. Government Initiatives – Summary Changes in tax structure Control programmes Government Initiatives PPP Projects Reduction in drug prices ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT 6
  7. 7. Major domestic players in the market (1/9) Company Snapshot: Company 1Corporate Information Financial Performance Revenue Revenue Profit Headquarters Location A INR bn INR bn Profit / Loss Founded 19-- 100 r4 60 r2 r3 r1 40 Products Product 1, product 2 50 20 Key People Person X– MD 0 0 2008 2009 2010 2011 Business Highlights • Employing around XX people, Company 1 is India’s largest pharmaceutical company, having manufacturing facilities in seven countries and serving customers in over YY countries • In June 20--, the company entered into an alliance with Company X to create an innovator and generic pharmaceuticals powerhouse • Company 1 launched anti-infectives such as Product 1 and Product 2 for the first time in India and is trying to promote the concept of product 3 on a local basis • Signed an agreement with Company X for manufacturing and marketing 3 new HIV/AIDS drugs in India and developing countries • Has been working on an anti-malaria research project since May 20-- to develop cheap anti malarial drugsSource: ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT 7
  8. 8. Thank you for the attentionThe Anti-Infective Pharmaceuticals Market – India report is part of Netscribes’ HealthcareIndustry Series.For more detailed information or customized research requirements please contact:Tamojit Roy Gagan UppalPhone: +91 33 4064 6215 Phone: +91 22 4098 7530E-Mail: tamojit.roy@netscribes.com E-Mail: gagan.uppal@netscribes.comResearch on India is a product of Netscribes (India) Pvt. Ltd. Research on India is dedicated to disseminating information and providing quickinsights on “hot” industries in India and other emerging markets. Track our new releases and major updates in these industries onAbout NetscribesNetscribes is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment &business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a truevalue proposition that draws upon a vast knowledge base. Netscribes is a one-stop shop designed to fulfil clients’ profitability and growthobjectives.Disclaimer: This report is published for general information only. Although high standards have been used the preparation, Research on India,Netscribes (India) Pvt. Ltd. or “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is thesole property of Netscribes (India) Pvt. Ltd. and prior permission is required for guidelines on reproduction. ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT 8

×